Epilepsy secondary to tuberous sclerosis

Lessons learned and current challenges

Romina Moavero, Caterina Cerminara, Paolo Curatolo

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background: In tuberous sclerosis complex (TSC), a substantially increased risk of developing epilepsy is present as a result of a disruption of a TSC gene expression in the brain and secondary abnormal cellular differentiation, migration, and proliferation. Dysregulated excitation probably has its roots in the disruption of GABAergic interneuron development. There is an age-dependent electroclinical expression of seizures, and epilepsy is often quite severe and unremitting. Discussion: The majority of patients (>60%) who are candidates for surgery remain seizure-free after tuberectomy. During the recent years technical advances in the localization of the epileptogenic zone during the recent years have lead to a 63% of Engel class I status after surgery compared with a previous 52%. In medically refractory patients not suitable for surgery, vagus nerve stimulation has proved efficacy in significantly reducing seizure frequency in more than 50% of cases. New evidence suggests that mTOR inhibitors may be helpful in the management of intractable epilepsy for individuals with TSC.

Original languageEnglish
Pages (from-to)1495-1504
Number of pages10
JournalChild's Nervous System
Volume26
Issue number11
DOIs
Publication statusPublished - Nov 2010

Fingerprint

Tuberous Sclerosis
Epilepsy
Seizures
Vagus Nerve Stimulation
Interneurons
Gene Expression
Brain

Keywords

  • Antiepileptic drugs
  • Epilepsy
  • Neurological outcome
  • Surgery
  • Tuberous sclerosis

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health

Cite this

Epilepsy secondary to tuberous sclerosis : Lessons learned and current challenges. / Moavero, Romina; Cerminara, Caterina; Curatolo, Paolo.

In: Child's Nervous System, Vol. 26, No. 11, 11.2010, p. 1495-1504.

Research output: Contribution to journalArticle

Moavero, Romina ; Cerminara, Caterina ; Curatolo, Paolo. / Epilepsy secondary to tuberous sclerosis : Lessons learned and current challenges. In: Child's Nervous System. 2010 ; Vol. 26, No. 11. pp. 1495-1504.
@article{ca81eda4696948549b62ae4f4fee7a11,
title = "Epilepsy secondary to tuberous sclerosis: Lessons learned and current challenges",
abstract = "Background: In tuberous sclerosis complex (TSC), a substantially increased risk of developing epilepsy is present as a result of a disruption of a TSC gene expression in the brain and secondary abnormal cellular differentiation, migration, and proliferation. Dysregulated excitation probably has its roots in the disruption of GABAergic interneuron development. There is an age-dependent electroclinical expression of seizures, and epilepsy is often quite severe and unremitting. Discussion: The majority of patients (>60{\%}) who are candidates for surgery remain seizure-free after tuberectomy. During the recent years technical advances in the localization of the epileptogenic zone during the recent years have lead to a 63{\%} of Engel class I status after surgery compared with a previous 52{\%}. In medically refractory patients not suitable for surgery, vagus nerve stimulation has proved efficacy in significantly reducing seizure frequency in more than 50{\%} of cases. New evidence suggests that mTOR inhibitors may be helpful in the management of intractable epilepsy for individuals with TSC.",
keywords = "Antiepileptic drugs, Epilepsy, Neurological outcome, Surgery, Tuberous sclerosis",
author = "Romina Moavero and Caterina Cerminara and Paolo Curatolo",
year = "2010",
month = "11",
doi = "10.1007/s00381-010-1128-8",
language = "English",
volume = "26",
pages = "1495--1504",
journal = "Child's Nervous System",
issn = "0256-7040",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - Epilepsy secondary to tuberous sclerosis

T2 - Lessons learned and current challenges

AU - Moavero, Romina

AU - Cerminara, Caterina

AU - Curatolo, Paolo

PY - 2010/11

Y1 - 2010/11

N2 - Background: In tuberous sclerosis complex (TSC), a substantially increased risk of developing epilepsy is present as a result of a disruption of a TSC gene expression in the brain and secondary abnormal cellular differentiation, migration, and proliferation. Dysregulated excitation probably has its roots in the disruption of GABAergic interneuron development. There is an age-dependent electroclinical expression of seizures, and epilepsy is often quite severe and unremitting. Discussion: The majority of patients (>60%) who are candidates for surgery remain seizure-free after tuberectomy. During the recent years technical advances in the localization of the epileptogenic zone during the recent years have lead to a 63% of Engel class I status after surgery compared with a previous 52%. In medically refractory patients not suitable for surgery, vagus nerve stimulation has proved efficacy in significantly reducing seizure frequency in more than 50% of cases. New evidence suggests that mTOR inhibitors may be helpful in the management of intractable epilepsy for individuals with TSC.

AB - Background: In tuberous sclerosis complex (TSC), a substantially increased risk of developing epilepsy is present as a result of a disruption of a TSC gene expression in the brain and secondary abnormal cellular differentiation, migration, and proliferation. Dysregulated excitation probably has its roots in the disruption of GABAergic interneuron development. There is an age-dependent electroclinical expression of seizures, and epilepsy is often quite severe and unremitting. Discussion: The majority of patients (>60%) who are candidates for surgery remain seizure-free after tuberectomy. During the recent years technical advances in the localization of the epileptogenic zone during the recent years have lead to a 63% of Engel class I status after surgery compared with a previous 52%. In medically refractory patients not suitable for surgery, vagus nerve stimulation has proved efficacy in significantly reducing seizure frequency in more than 50% of cases. New evidence suggests that mTOR inhibitors may be helpful in the management of intractable epilepsy for individuals with TSC.

KW - Antiepileptic drugs

KW - Epilepsy

KW - Neurological outcome

KW - Surgery

KW - Tuberous sclerosis

UR - http://www.scopus.com/inward/record.url?scp=78649330303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649330303&partnerID=8YFLogxK

U2 - 10.1007/s00381-010-1128-8

DO - 10.1007/s00381-010-1128-8

M3 - Article

VL - 26

SP - 1495

EP - 1504

JO - Child's Nervous System

JF - Child's Nervous System

SN - 0256-7040

IS - 11

ER -